case report | Q2782326 |
scholarly article | Q13442814 |
P50 | author | Charalambos Antoniades | Q89090660 |
Dimitris Tousoulis | Q90167660 | ||
Marietta Charakida | Q114337061 | ||
Kyriakoula Marinou | Q114563429 | ||
Carmen Vasiliadou | Q117271859 | ||
Katerina Koniari | Q125323163 | ||
Ioannis Ntarladimas | Q125329942 | ||
Pantelis Kourtellaris | Q125331674 | ||
Christodoulos I. Stefanadis | Q17308889 | ||
Gerasimos Siasos | Q54165911 | ||
P2860 | cites work | Diabetes and endothelial dysfunction: a clinical perspective | Q31835799 |
Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase | Q34145182 | ||
The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor | Q35557336 | ||
Evaluating endothelial function in humans: a guide to invasive and non-invasive techniques | Q36072672 | ||
Statins for all patients with type 2 diabetes: not so soon | Q80484606 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | type 2 diabetes | Q3025883 |
vitamin C | Q199678 | ||
P304 | page(s) | 244-246 | |
P577 | publication date | 2006-08-16 | |
P1433 | published in | Heart | Q856338 |
P1476 | title | Effects of atorvastatin and vitamin C on forearm hyperaemic blood flow, asymmentrical dimethylarginine levels and the inflammatory process in patients with type 2 diabetes mellitus | |
P478 | volume | 93 |
Q38780360 | Antioxidant properties of drugs used in Type 2 diabetes management: could they contribute to, confound or conceal effects of antioxidant therapy? |
Q36448338 | Association between circulating ascorbic acid, α-tocopherol, 25-hydroxyvitamin D, and plasma cytokine concentrations in young adults: a cross-sectional study |
Q52632609 | Asymmetric Dimethyl Arginine as a Biomarker of Atherosclerosis in Rheumatoid Arthritis. |
Q46904973 | Atorvastatin improves erectile dysfunction in patients initially irresponsive to Sildenafil by the activation of endothelial nitric oxide synthase |
Q37889812 | Coenzyme Q(10) , endothelial function, and cardiovascular disease. |
Q38151942 | Effect of antioxidant vitamin supplementation on endothelial function in type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. |
Q36308196 | Effects of vitamin C supplementation on glycaemic control: a systematic review and meta-analysis of randomised controlled trials |
Q33776230 | Endothelial dysfunction in diabetes: pathogenesis, significance, and treatment |
Q38231099 | Inflammation and cardiovascular disease: from pathogenesis to therapeutic target. |
Q36881730 | Inflammation in the vascular bed: importance of vitamin C |
Q64386241 | Mitochondria and cardiovascular diseases-from pathophysiology to treatment |
Q37798006 | Novel therapeutic strategies targeting vascular endothelium in essential hypertension |
Q37406657 | Role of vitamin C in the function of the vascular endothelium |
Q36088110 | Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials. |
Q33870395 | Therapeutic interventions and oxidative stress in diabetes |
Q36892489 | Therapeutic regulation of endothelial dysfunction in type 2 diabetes mellitus. |
Q34605273 | Vitamins D, C, and E in the prevention of type 2 diabetes mellitus: modulation of inflammation and oxidative stress. |
Search more.